Corpus ID: 25908964

[Glucose/insulin response to a glucose overload in subjects at risk for type 2 diabetes].

@article{Ryder2001GlucoseinsulinRT,
  title={[Glucose/insulin response to a glucose overload in subjects at risk for type 2 diabetes].},
  author={Elena Ryder and M E G{\'o}mez and Virginia Fern{\'a}ndez and Gilberto Campos and Luz Marina Morales and Humberto Alejandro Rosales Valbuena and Xiomara Raleigh},
  journal={Investigacion clinica},
  year={2001},
  volume={42 4},
  pages={
          269-81
        }
}
With the purpose of determining how certain risk factors for type 2 diabetes such as family history of diabetes, obesity and dyslipidemia, affect the glucose-insulin response to a glucose challenge, 135 individuals (77 women and 58) men were studied. Their ages ranged from 20-68 years, their basal glycemic values were less than 110 mg/dL but they were considered at risk for diabetes due to the presence of one or more of those factors. We found that the presence of those risk factors did not… Expand
Presence of impaired insulin secretion and insulin resistance in normoglycemic male subjects with family history of type 2 diabetes.
In order to demonstrate the effect of family history (FH) coexisting with obesity in insulin resistance (IR) and secretion in subjects at risk for type 2 diabetes, fasting and 2 h post-glucose loadExpand
Transcultural Diabetes Nutrition Algorithm (tDNA): Venezuelan Application
TLDR
The development of tDNA-Venezuelan via analysis of region-specific cardiovascular disease (CVD) risk factors, lifestyles, anthropometrics, and resultant tDNA algorithmic modifications is detailed. Expand
Beneficial effects of IH-901 on glucose and lipid metabolisms via activating adenosine monophosphate-activated protein kinase and phosphatidylinositol-3 kinase pathways.
TLDR
Protein and gene expression patterns for adenosine monophosphate-activated protein kinase, sterol regulatory element binding protein-1a, and glucose transporter 4 in the liver and skeletal muscles were similar to those in cell studies, suggesting IH-901 might be a promising therapeutic agent improving altered glucose and lipid metabolisms revealed in type 2 diabetes mellitus patients. Expand